Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

Also called NCT01710007

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 202 participants (enrolled count) (from the registry)
Sponsor
Orient Pharma Co., Ltd. (from the registry)
Registry
  • NCT NCT01710007
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01710007. Randomized; double masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2023-07-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia
Condition
Hypercholesterolemia
Intervention (Drug)
1PC002
Intervention (Drug)
Lipitor
Lead sponsor
Orient Pharma Co., Ltd. (class: industry)
Collaborator
Orient Europharma Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01710007
Content hash
d49eb4eb2922764d321d0853c2ee765c98fa520c073f433ed0ce962e6b2a04b2